IRadimed CorporationIRMDNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+20.5%
5Y CAGR+117.7%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+20.5%/yr
vs +23.1%/yr prior
5Y CAGR
+117.7%/yr
Recent deceleration
Acceleration
-2.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
49x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$28.53M+25.2%
2024$22.78M+9.5%
2023$20.80M+27.6%
2022$16.30M+45.2%
2021$11.22M+1826.2%
2020$582733.00-94.1%
2019$9.89M+39.1%
2018$7.11M+174.1%
2017$2.59M-76.8%
2016$11.17M-